sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Stake in Mural Oncology
The Vanguard Group, Inc. has filed a Form 8.3 relating to Mural Oncology plc. The disclosure, submitted under the Irish Takeover Panel Act, reveals The Vanguard Group holds a significant interest, with 772,885 ordinary shares representing 4.48% of Mural Oncology's relevant securities. The document indicates no additional disclosures for other parties involved in potential offers.
The record, dated 22 May 2025, specifies that there were sales of 36 shares at 2.75 USD per unit. No cash-settled or stock-settled derivative transactions were reported. Moreover, no new agreements, indemnities, or understandings relevant to securities dealings have been entered.
The disclosure is in compliance with Rule 8.3, requiring declarations by individuals with interests exceeding 1% in relevant securities of a company subject to takeover rules.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.